From the epicentre of Italy’s pandemic: Take care and keep steady
EASL-ESCMID Position Paper: Patients with advanced liver disease and transplant recipients require specific care during COVID-19
The European Association for the Study of the Liver (EASL) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) have issued a Position Paper, providing recommendations for clinicians caring for patients with liver diseases during the current pandemic.…
BioMed Alliance submits Joint Statement to EU leaders, as COVID-19 threatens medical associations
Subsequent to the disruption caused by the COVID-19 pandemic, EASL and 32 other leading European medical associations – together forming the Biomedical Alliance in Europe (BioMed Alliance) – have submitted a joint statement to EU leaders. Together, we are calling…
EASL postpones ILC 2020 until August
13 March 2020 Given the ongoing developments with COVID-19, EASL has postponed the International Liver CongressTM (ILC 2020) that was scheduled for 15-19 April 2020 in London. Having reviewed the situation, and after taking extensive advice, we have decided on…
Experts discuss latest research and future of liver cancer
Over 600 delegates from 44 countries gathered in Prague at the EASL Liver Cancer Summit 2020 to discuss latest developments and the future of liver cancer research. Organised annually by EASL, the European Association for the Study of the Liver,…
EASL Postgraduate course now available in Chinese, Japanese, Portuguese and Spanish
Every year, the EASL Postgraduate course highlights many clinical practice dilemmas and engages the audience with world-renowned experts on how to make the best management decisions to help patients with liver disease. This year’s postgraduate course at the International Liver…
Discover EASL Campus – your open-access eLearning hub for hepatology and liver-related disease
We’re pleased to announce the launch of our improved multi-disciplinary eLearning hub, EASL Campus, designed to help you develop your hepatology and liver-related disease knowledge through a variety of open-access, high quality and interactive resources tailored to your specialism and…
Global hepatology societies call for better HCV testing and access to treatment
Four societies focused on liver disease research and treatment announced a global call-to-action initiative to simplify hepatitis C testing and treatment. BOSTON, 8 November 2019. The societies, in partnership with the Clinton Health Access Initiative (CHAI), launched the initiative at…